Blood Test May Indicate Early Warning Signs Of Skin Cancer Relapse

A simple blood test may indicate the warning signs of relapse in patients with advanced melanoma skin cancer.

"Being able to spot the first signs of relapse, so we can rapidly decide the best treatment strategy, is an important area for research," said lead study author Richard Marais, skin cancer expert at Cancer Research UK, a leading cancer charity dedicated to saving lives through research.

Skin Cancer - Types, Causes, Symptoms, Diagnosis, Treatment & Prevention
Skin cancer is an abnormal growth of skin cells. It can develop due to a continuous exposure to sun over the years.

‘The mutation in genes NRAS and PI3K causes the remission of skin cancer, allowing the tumor to become resistant to treatment. ’

Tweet it Now

"Using our technique we hope that one day we will be able to spot when a patient's disease is coming back at the earliest point and start treatment against this much sooner, hopefully giving patients more time with their loved ones," Marais noted.

The researchers studied the DNA shed by tumors into the bloodstream -- called circulating tumor DNA -- in blood samples from seven advanced melanoma patients.

In this early work they found they could see whether a patient was relapsing by tracking levels of circulating tumor DNA.

Australian Actor Hugh Jackman Raises Skin Cancer Awareness
The 'X-men' actor, Hugh Jackman was diagnosed with skin cancer for the fifth time and underwent a surgery to remove the cancer blot.

And they found that new mutations in genes like NRAS and PI3K appeared, possibly causing the relapse by allowing the tumor to become resistant to treatment.

Most melanoma patients respond to treatment at first but their cancer can become resistant within a year.

Australian Swimmer Susie Maroney Diagnosed with Skin Cancer
The 41-year-old mother-of-three was diagnosed with skin cancer following the discovery of a malignant melanoma on her back.

It is hoped that these approaches will allow doctors to use circulating tumor DNA to tailor treatment for individual patients to get the best result.

The findings were published in the journal Cancer Discovery.

Scientists Reduce Progression of the Most Aggressive Skin Cancers in Mice
The c-Fos oncogene has traditionally been linked to cellular activities related to cancer, such as differentiation—conversion from one cell type to another— cell division or survival.

Source-IANS